Can we use the same population for both? Eltopr
Post# of 30028
Posted On: 08/13/2014 11:37:12 PM
Can we use the same population for both?
Eltoprazine:
We expect significant announcements to begin regarding our mid-clinical stage therapeutic program Eltoprazine, including the initiation of our 200 patient Phase 2b clinical trial for Parkinson’s disease Levadopa-Induced Dyskinesia (PD-LID);
NuroPro® Blood Test
Current Status: The Parkinson’s disease application of the NuroPro® Blood Test has completed proof-of-concept and Phase 1 clinical validation studies. Amarantus is preparing the Phase 2 validation study required to gain Clinical Laboratory Improvement Amendments (CLIA) certification. Upon CLIA certification, the Company intends to begin the commercial sale of the NuroPro Parkinson’s Disease Blood Test.
Eltoprazine:
We expect significant announcements to begin regarding our mid-clinical stage therapeutic program Eltoprazine, including the initiation of our 200 patient Phase 2b clinical trial for Parkinson’s disease Levadopa-Induced Dyskinesia (PD-LID);
NuroPro® Blood Test
Current Status: The Parkinson’s disease application of the NuroPro® Blood Test has completed proof-of-concept and Phase 1 clinical validation studies. Amarantus is preparing the Phase 2 validation study required to gain Clinical Laboratory Improvement Amendments (CLIA) certification. Upon CLIA certification, the Company intends to begin the commercial sale of the NuroPro Parkinson’s Disease Blood Test.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼